Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pain ManagementVeterinary Medicine

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1379684

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1379684

APAC Veterinary Pain Management Market - Industry Trends and Forecast to 2031

PUBLISHED:
PAGES: 229 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Description

Table of Contents

List of Tables

Asia-Pacific veterinary pain management market is expected to reach USD 586,635.95 thousand by 2030 from USD 409,355.09 thousand in 2022 growing at a CAGR of 4.7% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation

Asia Pacific Veterinary Pain Management Market, By Product Type (Analgesics, Corticosteroids, and Alpha 2 Agonists), Drug Type (Branded and Generic), Mode of Purchase (Prescription Based and OTC), Animal Type (Companion Animal and Production Animal), Pain Source (Chronic Pain, Acute Pain, Post-Operative Pain, and Dental Pain), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Parenteral, Oral, and Topical), End User (Veterinary Hospitals, Veterinary Clinics, Pet Shops, Animal Farms, Academic & Research Institutes, and Others), Country (China, Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Taiwan, Vietnam, and rest of Asia-Pacific) - Industry Trends and Forecast to 2030.

Overview of Asia Pacific Veterinary Pain Management Market Dynamics

  • Driver
  • Rising incidences of pet diseases
  • Restraint
  • High costs of pet care
  • Opportunity
  • Technological advancements for pain management

Market Players

Some of the major market players operating in the Asia-Pacific veterinary pain management market are:

  • Dechra Pharmaceuticals PLC
  • Virbac
  • Norbrook
  • Bimeda, Inc.
  • Inovet ( A subsidiary of Orion Group)
  • Chanelle Pharma
  • Vetoquinol
  • Elanco
  • Merck & Co., Inc.
  • Ceva Animal Health, LLC
Show more

TABLE OF CONTENTS

1 INTRODUCTION 26

  • 1.1 OBJECTIVES OF THE STUDY 26
  • 1.2 MARKET DEFINITION 26
  • 1.3 OVERVIEW OF THE ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET 26
  • 1.4 CURRENCY AND PRICING 28
  • 1.5 LIMITATIONS 28
  • 1.6 MARKETS COVERED 29

2 MARKET SEGMENTATION 32

  • 2.1 MARKETS COVERED 32
  • 2.2 GEOGRAPHICAL SCOPE 33
  • 2.3 YEARS CONSIDERED FOR THE STUDY 34
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 35
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
  • 2.6 MULTIVARIATE MODELLING 39
  • 2.7 MARKET END USER COVERAGE GRID 39
  • 2.8 PRODUCT LIFELINE CURVE 40
  • 2.9 DBMR MARKET POSITION GRID 41
  • 2.10 VENDOR SHARE ANALYSIS 42
  • 2.11 SECONDARY SOURCES 43
  • 2.12 ASSUMPTIONS 43

3 EXECUTIVE SUMMARY 44

4 PREMIUM INSIGHTS 47

  • 4.1 PESTEL ANALYSIS 48
  • 4.2 PORTER'S FIVE FORCES 49
  • 4.3 BRAND REVENUE ANALYSIS 50

5 MARKET OVERVIEW 51

  • 5.1 DRIVERS 53
    • 5.1.1 INCREASING PET OWNERSHIP 53
    • 5.1.2 ADVANCEMENTS IN VETERINARY MEDICINE 53
    • 5.1.3 GROWING INCIDENCES OF PET DISEASES 54
    • 5.1.4 INCREASED GOVERNMENT PROJECTS TO ENHANCE ANIMAL CARE 54
  • 5.2 RESTRAINTS 55
    • 5.2.1 INCREASING PET CARE COSTS 55
    • 5.2.2 STRICT REGULATORY GUIDELINES 55 
  • 5.3 OPPORTUNITIES 56
    • 5.3.1 RISING R&D ACTIVITIES AND PRODUCT APPROVAL FOR VETERINARY PAIN MANAGEMENT 56
    • 5.3.2 RISING POPULARITY OF NON- CONVENTIONAL TREATMENT APPROACHES 57
    • 5.3.3 TECHNOLOGICAL ADVANCEMENTS 57
  • 5.4 CHALLENGES 58
    • 5.4.1 LIMITED AVAILABILITY OF VETERINARIANS 58
    • 5.4.2 RESISTANCE TO MEDICATIONS 58

6 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE 59

  • 6.1 OVERVIEW 60
  • 6.2 ANALGESICS 61
    • 6.2.1 ANTI- INFLAMMATORY (NSAIDS) 61
      • 6.2.1.1 CARPROFEN 62
      • 6.2.1.2 MELOXICAM 62
      • 6.2.1.3 PHENYLBUTAZONE 62
      • 6.2.1.4 ACETAMINOPHEN 62
      • 6.2.1.5 FIROCOXIB 62
      • 6.2.1.6 DERACOXIB 62
      • 6.2.1.7 OTHERS 63
    • 6.2.2 OPIOIDS 63
      • 6.2.2.1 MU AGONISTS 63
        • 6.2.2.1.1 METHADONE 64
        • 6.2.2.1.2 MEPERIDINE 64
        • 6.2.2.1.3 MORPHINE 64
        • 6.2.2.1.4 OXYMORPHONE 64
        • 6.2.2.1.5 OTHERS 64
      • 6.2.2.2 PARTIAL MU AGONIST 64
        • 6.2.2.2.1 BUPRENORPHINE 64
        • 6.2.2.2.2 OTHERS 65
      • 6.2.2.3 KAPPA AGONIST MU ANTAGONIST 65
        • 6.2.2.3.1 BUTORPHANOL 65
        • 6.2.2.3.2 OTHERS 65
  • 6.3 CORTICOSTEROIDS 66
    • 6.3.1 DEXAMETHASONE 66
    • 6.3.2 PREDNISOLONE 66
    • 6.3.3 PREDNISONE 66
    • 6.3.4 OTHERS 67
  • 6.4 ALPHA 2 AGONISTS 67 

7 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE 68

  • 7.1 OVERVIEW 69
  • 7.2 BRANDED 70
  • 7.3 GENERIC 70

8 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE 71

  • 8.1 OVERVIEW 72
  • 8.2 PRESCRIPTION BASED 73
  • 8.3 OTC 73

9 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 74

  • 9.1 OVERVIEW 75
  • 9.2 COMPANION ANIMAL 76
    • 9.2.1 CANINE 77
    • 9.2.2 EQUINE 77
    • 9.2.3 FELINE 77
    • 9.2.4 OTHERS 77
  • 9.3 PRODUCTION ANIMAL 77
    • 9.3.1 CATTLE 78
    • 9.3.2 SWINE 78
    • 9.3.3 POULTRY 78
    • 9.3.4 FISH 78
    • 9.3.5 OTHERS 78

10 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE 79

  • 10.1 OVERVIEW 80
  • 10.2 CHRONIC PAIN 81
  • 10.3 ACUTE PAIN 82
  • 10.4 POST OPERATIVE PAIN 82
  • 10.5 DENTAL PAIN 83

11 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE 84

  • 11.1 OVERVIEW 85
  • 11.2 SOLID 86
    • 11.2.1 TABLET 86
    • 11.2.2 POWDER 87
    • 11.2.3 OTHERS 87 
  • 11.3 LIQUID 87
    • 11.3.1 SOLUTION 87
    • 11.3.2 SYRUP 88
    • 11.3.3 SUSPENSION 88
    • 11.3.4 OTHERS 88
  • 11.4 SEMI SOLID 88
    • 11.4.1 GEL 89
    • 11.4.2 CREAM 89
    • 11.4.3 OTHERS 89

12 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION 90

  • 12.1 OVERVIEW 91
  • 12.2 PARENTERAL 92
  • 12.3 ORAL 93
  • 12.4 TOPICAL 93

13 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY END USER 94

  • 13.1 OVERVIEW 95
  • 13.2 VETERINARY HOSPITALS 96
  • 13.3 VETERINARY CLINICS 97
  • 13.4 PET SHOPS 97
  • 13.5 ANIMAL FARMS 98
  • 13.6 ACADEMIC & RESEARCH INSTITUTES 98
  • 13.7 OTHERS 99

14 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY GEOGRAPHY 100

  • 14.1 ASIA PACIFIC 101
    • 14.1.1 CHINA 109
    • 14.1.2 AUSTRALIA 116
    • 14.1.3 INDIA 123
    • 14.1.4 JAPAN 130
    • 14.1.5 SINGAPORE 137
    • 14.1.6 INDONESIA 144
    • 14.1.7 MALAYSIA 151
    • 14.1.8 NEW ZEALAND 158
    • 14.1.9 SOUTH KOREA 165
    • 14.1.10 VIETNAM 172
    • 14.1.11 THAILAND 179
    • 14.1.12 PHILIPPINES 186
    • 14.1.13 TAIWAN 193
    • 14.1.14 REST OF ASIA-PACIFIC 200

15 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, COMPANY LANDSCAPE 201

  • 15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 201

16 SWOT ANALYSIS 202

17 COMPANY PROFILE 203

  • 17.1 ZOETIS SERVICES LLC 203
    • 17.1.1 COMPANY SNAPSHOT 203
    • 17.1.2 COMPANY SHARE ANALYSIS 203
    • 17.1.3 PRODUCT PORTFOLIO 204
    • 17.1.4 RECENT DEVELOPMENTS 204
  • 17.2 ELANCO 205
    • 17.2.1 COMPANY SNAPSHOT 205
    • 17.2.2 REVENUE ANALYSIS 205
    • 17.2.3 COMPANY SHARE ANALYSIS 206
    • 17.2.4 PRODUCT PORTFOLIO 206
    • 17.2.5 RECENT DEVELOPMENT 206
  • 17.3 MERCK & CO., INC. 207
    • 17.3.1 COMPANY SNAPSHOT 207
    • 17.3.2 REVENUE ANALYSIS 207
    • 17.3.3 COMPANY SHARE ANALYSIS 208
    • 17.3.4 PRODUCT PORTFOLIO 208
    • 17.3.5 RECENT DEVELOPMENT 208
  • 17.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 209
    • 17.4.1 COMPANY SNAPSHOT 209
    • 17.4.2 COMPANY SHARE ANALYSIS 209
    • 17.4.3 PRODUCT PORTFOLIO 210
    • 17.4.4 RECENT DEVELOPMENT 210
  • 17.5 VETOQUINOL 211
    • 17.5.1 COMPANY SNAPSHOT 211
    • 17.5.2 REVENUE ANALYSIS 211
    • 17.5.3 COMPANY SHARE ANALYSIS 212
    • 17.5.4 PRODUCT PORTFOLIO 212
    • 17.5.5 RECENT DEVELOPMENTS 212
  • 17.6 BIMEDA, INC. 214
    • 17.6.1 COMPANY SNAPSHOT 214
    • 17.6.2 PRODUCT PORTFOLIO 214
    • 17.6.3 RECENT DEVELOPMENT 214 
  • 17.7 CEVA ANIMAL HEALTH, LLC 215
    • 17.7.1 COMPANY SNAPSHOT 215
    • 17.7.2 PRODUCT PORTFOLIO 215
    • 17.7.3 RECENT DEVELOPMENT 215
  • 17.8 CHANELLE PHARMA 216
    • 17.8.1 COMPANY SNAPSHOT 216
    • 17.8.2 PRODUCT PORTFOLIO 216
    • 17.8.3 RECENT DEVELOPMENT 216
  • 17.9 DECHRA PHARMACEUTICALS PLC 217
    • 17.9.1 COMPANY SNAPSHOT 217
    • 17.9.2 REVENUE ANALYSIS 217
    • 17.9.3 PRODUCT PORTFOLIO 218
    • 17.9.4 RECENT DEVELOPMENTS 218
  • 17.10 DURVET ANIMAL HEALTH PRODUCTS 219
    • 17.10.1 COMPANY SNAPSHOT 219
    • 17.10.2 PRODUCT PORTFOLIO 219
    • 17.10.3 RECENT DEVELOPMENT 219
  • 17.11 INOVET (A SUBSIDIARY OF ORION GROUP) 220
    • 17.11.1 COMPANY SNAPSHOT 220
    • 17.11.2 PRODUCT PORTFOLIO 220
    • 17.11.3 RECENT DEVELOPMENTS 220
  • 17.12 NORBROOK 222
    • 17.12.1 COMPANY SNAPSHOT 222
    • 17.12.2 PRODUCT PORTFOLIO 222
    • 17.12.3 RECENT DEVELOPMENT 222
  • 17.13 VIRBAC 223
    • 17.13.1 COMPANY SNAPSHOT 223
    • 17.13.2 REVENUE ANALYSIS 223
    • 17.13.3 PRODUCT PORTFOLIO 224
    • 17.13.4 RECENT DEVELOPMENT 224

18 QUESTIONNAIRE 225

19 RELATED REPORTS 229

Show more

LIST OF TABLES

  • TABLE 1 BRAND REVENUE ANALYSIS FOR VETERINARY PAIN MANAGEMENT MARKET 50
  • TABLE 2 NUMBER OF U.S. HOUSEHOLD-OWNED PET ANIMALS 53
  • TABLE 3 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 61
  • TABLE 4 ASIA-PACIFIC ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 61
  • TABLE 5 ASIA-PACIFIC ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 61
  • TABLE 6 ASIA-PACIFIC ANTI- INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 62
  • TABLE 7 ASIA-PACIFIC OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 63
  • TABLE 8 ASIA-PACIFIC MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 63
  • TABLE 9 ASIA-PACIFIC PARTIAL MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 64
  • TABLE 10 ASIA-PACIFIC KAPPA AGONIST MU ANTAGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 65
  • TABLE 11 ASIA-PACIFIC CORTICOSTEROIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 66
  • TABLE 12 ASIA-PACIFIC CORTICOSTEROIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 66
  • TABLE 13 ASIA-PACIFIC ALPHA-2 AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
  • TABLE 14 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 70
  • TABLE 15 ASIA-PACIFIC BRANDED IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
  • TABLE 16 ASIA-PACIFIC GENERIC IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
  • TABLE 17 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 73
  • TABLE 18 ASIA-PACIFIC PRESCRIPTION BASED IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
  • TABLE 19 ASIA-PACIFIC OTC IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
  • TABLE 20 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 76
  • TABLE 21 ASIA-PACIFIC COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
  • TABLE 22 ASIA-PACIFIC COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 76
  • TABLE 23 ASIA-PACIFIC PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 77
  • TABLE 24 ASIA-PACIFIC PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 78
  • TABLE 25 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 81
  • TABLE 26 ASIA-PACIFIC CHRONIC PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
  • TABLE 27 ASIA-PACIFIC ACUTE PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
  • TABLE 28 ASIA-PACIFIC POST OPERATIVE PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
  • TABLE 29 ASIA-PACIFIC DENTAL PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 83
  • TABLE 30 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 86
  • TABLE 31 ASIA-PACIFIC SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
  • TABLE 32 ASIA-PACIFIC SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 86
  • TABLE 33 ASIA-PACIFIC LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
  • TABLE 34 ASIA-PACIFIC LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 87
  • TABLE 35 ASIA-PACIFIC SEMI SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 88
  • TABLE 36 ASIA-PACIFIC SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 88
  • TABLE 37 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 92
  • TABLE 38 ASIA-PACIFIC PARENTERAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 92
  • TABLE 39 ASIA-PACIFIC ORAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 93
  • TABLE 40 ASIA-PACIFIC TOPICAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 93
  • TABLE 41 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 96
  • TABLE 42 ASIA-PACIFIC VETERINARY HOSPITALS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
  • TABLE 43 ASIA-PACIFIC VETERINARY CLINICS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
  • TABLE 44 ASIA-PACIFIC PET SHOPS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
  • TABLE 45 ASIA-PACIFIC ANIMAL FARMS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
  • TABLE 46 ASIA-PACIFIC ACADEMIC & RESEARCH INSTITUTES IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
  • TABLE 47 ASIA-PACIFIC OTHERS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 99
  • TABLE 48 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 101
  • TABLE 49 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
  • TABLE 50 ASIA-PACIFIC ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
  • TABLE 51 ASIA-PACIFIC ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
  • TABLE 52 ASIA-PACIFIC OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 103
  • TABLE 53 ASIA-PACIFIC MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 103
  • TABLE 54 ASIA-PACIFIC PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 103
  • TABLE 55 ASIA-PACIFIC KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 104
  • TABLE 56 ASIA-PACIFIC CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 104
  • TABLE 57 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 104
  • TABLE 58 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 105
  • TABLE 59 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 105
  • TABLE 60 ASIA-PACIFIC COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 105
  • TABLE 61 ASIA-PACIFIC PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 106
  • TABLE 62 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 106
  • TABLE 63 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 106
  • TABLE 64 ASIA-PACIFIC SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 107
  • TABLE 65 ASIA-PACIFIC LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 107
  • TABLE 66 ASIA-PACIFIC SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 107
  • TABLE 67 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 108
  • TABLE 68 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 108
  • TABLE 69 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
  • TABLE 70 CHINA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
  • TABLE 71 CHINA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
  • TABLE 72 CHINA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
  • TABLE 73 CHINA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
  • TABLE 74 CHINA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
  • TABLE 75 CHINA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 111
  • TABLE 76 CHINA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 111
  • TABLE 77 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 111
  • TABLE 78 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 112
  • TABLE 79 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 112
  • TABLE 80 CHINA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 112
  • TABLE 81 CHINA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 113
  • TABLE 82 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 113
  • TABLE 83 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 113
  • TABLE 84 CHINA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 114
  • TABLE 85 CHINA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 114
  • TABLE 86 CHINA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 114
  • TABLE 87 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 115
  • TABLE 88 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 115
  • TABLE 89 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
  • TABLE 90 AUSTRALIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
  • TABLE 91 AUSTRALIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
  • TABLE 92 AUSTRALIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
  • TABLE 93 AUSTRALIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
  • TABLE 94 AUSTRALIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
  • TABLE 95 AUSTRALIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
  • TABLE 96 AUSTRALIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
  • TABLE 97 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 118
  • TABLE 98 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 119
  • TABLE 99 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 119
  • TABLE 100 AUSTRALIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 119
  • TABLE 101 AUSTRALIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 120
  • TABLE 102 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 120
  • TABLE 103 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 120
  • TABLE 104 AUSTRALIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 121
  • TABLE 105 AUSTRALIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 121
  • TABLE 106 AUSTRALIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 121
  • TABLE 107 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 122
  • TABLE 108 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 122
  • TABLE 109 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
  • TABLE 110 INDIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
  • TABLE 111 INDIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
  • TABLE 112 INDIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
  • TABLE 113 INDIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
  • TABLE 114 INDIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
  • TABLE 115 INDIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
  • TABLE 116 INDIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
  • TABLE 117 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 125
  • TABLE 118 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 126
  • TABLE 119 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 126
  • TABLE 120 INDIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 126
  • TABLE 121 INDIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 127
  • TABLE 122 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 127
  • TABLE 123 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 127
  • TABLE 124 INDIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 128
  • TABLE 125 INDIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 128
  • TABLE 126 INDIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 128
  • TABLE 127 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 129
  • TABLE 128 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 129
  • TABLE 129 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 129
  • TABLE 130 JAPAN ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
  • TABLE 131 JAPAN ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
  • TABLE 132 JAPAN OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
  • TABLE 133 JAPAN MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
  • TABLE 134 JAPAN PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
  • TABLE 135 JAPAN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
  • TABLE 136 JAPAN CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
  • TABLE 137 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 132
  • TABLE 138 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 133
  • TABLE 139 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 133
  • TABLE 140 JAPAN COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 133
  • TABLE 141 JAPAN PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 134
  • TABLE 142 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 134
  • TABLE 143 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 134
  • TABLE 144 JAPAN SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 135
  • TABLE 145 JAPAN LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 135
  • TABLE 146 JAPAN SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 135
  • TABLE 147 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 136
  • TABLE 148 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 136
  • TABLE 149 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
  • TABLE 150 SINGAPORE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
  • TABLE 151 SINGAPORE ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
  • TABLE 152 SINGAPORE OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
  • TABLE 153 SINGAPORE MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
  • TABLE 154 SINGAPORE PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
  • TABLE 155 SINGAPORE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
  • TABLE 156 SINGAPORE CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
  • TABLE 157 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 139
  • TABLE 158 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 140
  • TABLE 159 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 140
  • TABLE 160 SINGAPORE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 140
  • TABLE 161 SINGAPORE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 141
  • TABLE 162 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 141
  • TABLE 163 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 141
  • TABLE 164 SINGAPORE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 142
  • TABLE 165 SINGAPORE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 142
  • TABLE 166 SINGAPORE SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 142
  • TABLE 167 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 143
  • TABLE 168 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 143
  • TABLE 169 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
  • TABLE 170 INDONESIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
  • TABLE 171 INDONESIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
  • TABLE 172 INDONESIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
  • TABLE 173 INDONESIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
  • TABLE 174 INDONESIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
  • TABLE 175 INDONESIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
  • TABLE 176 INDONESIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
  • TABLE 177 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 146
  • TABLE 178 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 147
  • TABLE 179 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 147
  • TABLE 180 INDONESIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 147
  • TABLE 181 INDONESIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 148
  • TABLE 182 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 148
  • TABLE 183 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 149
  • TABLE 184 INDONESIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 149
  • TABLE 185 INDONESIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 149
  • TABLE 186 INDONESIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 150
  • TABLE 187 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 150
  • TABLE 188 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 150
  • TABLE 189 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
  • TABLE 190 MALAYSIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
  • TABLE 191 MALAYSIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
  • TABLE 192 MALAYSIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
  • TABLE 193 MALAYSIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
  • TABLE 194 MALAYSIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
  • TABLE 195 MALAYSIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
  • TABLE 196 MALAYSIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
  • TABLE 197 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 153
  • TABLE 198 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 154
  • TABLE 199 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 154
  • TABLE 200 MALAYSIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 154
  • TABLE 201 MALAYSIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 155
  • TABLE 202 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 155
  • TABLE 203 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 155
  • TABLE 204 MALAYSIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 156
  • TABLE 205 MALAYSIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 156
  • TABLE 206 MALAYSIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 156
  • TABLE 207 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 157
  • TABLE 208 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 157
  • TABLE 209 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
  • TABLE 210 NEW ZEALAND ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
  • TABLE 211 NEW ZEALAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
  • TABLE 212 NEW ZEALAND OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
  • TABLE 213 NEW ZEALAND MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
  • TABLE 214 NEW ZEALAND PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
  • TABLE 215 NEW ZEALAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
  • TABLE 216 NEW ZEALAND CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
  • TABLE 217 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 160
  • TABLE 218 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 161
  • TABLE 219 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 161
  • TABLE 220 NEW ZEALAND COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 161
  • TABLE 221 NEW ZEALAND PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 162
  • TABLE 222 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 162
  • TABLE 223 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 163
  • TABLE 224 NEW ZEALAND SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 163
  • TABLE 225 NEW ZEALAND LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 163
  • TABLE 226 NEW ZEALAND SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 164
  • TABLE 227 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 164
  • TABLE 228 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 164
  • TABLE 229 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
  • TABLE 230 SOUTH KOREA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
  • TABLE 231 SOUTH KOREA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
  • TABLE 232 SOUTH KOREA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
  • TABLE 233 SOUTH KOREA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
  • TABLE 234 SOUTH KOREA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
  • TABLE 235 SOUTH KOREA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
  • TABLE 236 SOUTH KOREA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
  • TABLE 237 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 167
  • TABLE 238 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 168
  • TABLE 239 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 168
  • TABLE 240 SOUTH KOREA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 168
  • TABLE 241 SOUTH KOREA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 169
  • TABLE 242 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 169
  • TABLE 243 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 169
  • TABLE 244 SOUTH KOREA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 170
  • TABLE 245 SOUTH KOREA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 170
  • TABLE 246 SOUTH KOREA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 170
  • TABLE 247 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 171
  • TABLE 248 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 171
  • TABLE 249 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
  • TABLE 250 VIETNAM ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
  • TABLE 251 VIETNAM ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
  • TABLE 252 VIETNAM OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
  • TABLE 253 VIETNAM MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
  • TABLE 254 VIETNAM PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
  • TABLE 255 VIETNAM KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
  • TABLE 256 VIETNAM CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
  • TABLE 257 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 174
  • TABLE 258 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 175
  • TABLE 259 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 175
  • TABLE 260 VIETNAM COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 175
  • TABLE 261 VIETNAM PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 176
  • TABLE 262 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 176
  • TABLE 263 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 176
  • TABLE 264 VIETNAM SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 177
  • TABLE 265 VIETNAM LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 177
  • TABLE 266 VIETNAM SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 177
  • TABLE 267 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 178
  • TABLE 268 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 178
  • TABLE 269 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
  • TABLE 270 THAILAND ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
  • TABLE 271 THAILAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
  • TABLE 272 THAILAND OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
  • TABLE 273 THAILAND MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
  • TABLE 274 THAILAND PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
  • TABLE 275 THAILAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
  • TABLE 276 THAILAND CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
  • TABLE 277 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 181
  • TABLE 278 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 182
  • TABLE 279 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 182
  • TABLE 280 THAILAND COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 182
  • TABLE 281 THAILAND PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 183
  • TABLE 282 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 183
  • TABLE 283 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 183
  • TABLE 284 THAILAND SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 184
  • TABLE 285 THAILAND LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 184
  • TABLE 286 THAILAND SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 184
  • TABLE 287 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 185
  • TABLE 288 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 185
  • TABLE 289 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
  • TABLE 290 PHILIPPINES ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
  • TABLE 291 PHILIPPINES ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
  • TABLE 292 PHILIPPINES OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
  • TABLE 293 PHILIPPINES MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
  • TABLE 294 PHILIPPINES PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
  • TABLE 295 PHILIPPINES KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 188
  • TABLE 296 PHILIPPINES CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 188
  • TABLE 297 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 188
  • TABLE 298 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 189
  • TABLE 299 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 189
  • TABLE 300 PHILIPPINES COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 189
  • TABLE 301 PHILIPPINES PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 190
  • TABLE 302 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 190
  • TABLE 303 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 190
  • TABLE 304 PHILIPPINES SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 191
  • TABLE 305 PHILIPPINES LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 191
  • TABLE 306 PHILIPPINES SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 191
  • TABLE 307 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 192
  • TABLE 308 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 192
  • TABLE 309 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 193
  • TABLE 310 TAIWAN ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 193
  • TABLE 311 TAIWAN ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 193
  • TABLE 312 TAIWAN OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
  • TABLE 313 TAIWAN MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
  • TABLE 314 TAIWAN PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
  • TABLE 315 TAIWAN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 195
  • TABLE 316 TAIWAN CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 195
  • TABLE 317 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 195
  • TABLE 318 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 196
  • TABLE 319 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 196
  • TABLE 320 TAIWAN COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 196
  • TABLE 321 TAIWAN PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 197
  • TABLE 322 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 197
  • TABLE 323 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 197
  • TABLE 324 TAIWAN SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 198
  • TABLE 325 TAIWAN LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 198
  • TABLE 326 TAIWAN SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 198
  • TABLE 327 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 199
  • TABLE 328 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 199
  • TABLE 329 REST OF ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 200

LIST OF FIGURES

  • FIGURE 1 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: SEGMENTATION 32
  • FIGURE 2 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: DATA TRIANGULATION 35
  • FIGURE 3 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: DROC ANALYSIS 36
  • FIGURE 4 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS 37
  • FIGURE 5 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS 37
  • FIGURE 6 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS 38
  • FIGURE 7 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: MARKET END USER COVERAGE GRID 39
  • FIGURE 8 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: DBMR MARKET POSITION GRID 41
  • FIGURE 9 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: VENDOR SHARE ANALYSIS 42
  • FIGURE 10 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: SEGMENTATION 46
  • FIGURE 11 INCREASING PET OWNERSHIP AND ADVANCEMENTS IN VETERINARY MEDICINE ARE EXPECTED TO DRIVE THE GROWTH OF THE ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET FROM 2023 TO 2030 47
  • FIGURE 12 THE ANALGESICS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET IN 2023 & 2030 47
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES FOR ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET 52
  • FIGURE 14 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY PRODUCT TYPE, 2022 60
  • FIGURE 15 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY DRUG TYPE, 2022 69
  • FIGURE 16 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY MODE OF PURCHASE, 2022 72
  • FIGURE 17 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY ANIMAL TYPE, 2022 75
  • FIGURE 18 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY PAIN SOURCE, 2022 80
  • FIGURE 19 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY DOSAGE, 2022 85
  • FIGURE 20 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY ROUTE OF ADMINISTRATION, 2022 91
  • FIGURE 21 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY END USER, 2022 95
  • FIGURE 22 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: COMPANY SHARE 2022 (%) 201
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!